Medicover is expanding its fertility network into Norway
Medicover has acquired the Norwegian Fertility company Klinikk Hausken and acquired 70 per cent of the voting rights for 18.2 MEUR including assumed debt. Revenue for 2020 amounted to 6.5 MEUR. Klinikk Hausken is Norway’s leading private IVF group and consist of four clinics performing over 2,800 cycles per annum, with the Oslo facility being Norway’s largest private in-vitro clinic. “Klinikk Hausken is a very well managed company and a good fit to our fertility network and given the liberalisation of the Norwegian IVF legalisation the market is expected to grow significantly ahead.